Insider · CIK 0001677455

Parschauer Karah Herdman

Reports to the SEC for 5 companies · NOVATO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001677455

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−1,900 sh	$24.92	−$47.3K	92,562
2026-06-15	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−1,899 sh	$24.62	−$46.8K	94,462
2026-05-28	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+120K sh	—	—	120,000
2026-04-16	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Legal Officer	AAward	+28.9K sh	—	—	95,715
2026-04-16	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Legal Officer	AAward	+50K sh	—	—	49,960
2026-03-10	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−3,508 sh	$22.67	−$79.5K	66,820
2026-03-06	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−6,018 sh	$21.40	−$129K	70,328
2026-03-02	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−8,135 sh	$22.80	−$185K	76,346
2026-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Legal Officer	AAward	+11.1K sh	—	—	84,408
2026-02-17	EOLSEvolus, Inc.A Award	Director	AAward	+45.6K sh	—	—	77,742
2025-09-12	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−2,450 sh	$31.17	−$76.4K	73,271
2025-05-29	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+107K sh	—	—	107,400
2025-03-12	EOLSEvolus, Inc.S Sale	Director	SSale	−12.9K sh	$12.99	−$167K	32,183
2025-03-07	EOLSEvolus, Inc.A Award	Director	AAward	+7,364 sh	—	—	45,071
2025-03-07	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.1K sh	—	—	11,146
2025-03-03	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−12.8K sh	$42.10	−$541K	75,287
2025-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Legal Officer	AAward	+14.5K sh	—	—	69,690
2025-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Legal Officer	AAward	+26.1K sh	—	—	26,074
2025-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Legal Officer	AAward	+18.4K sh	—	—	88,133
2025-02-27	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−2,230 sh	$42.93	−$95.7K	55,751
2025-02-27	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−760 sh	$42.75	−$32.5K	54,991
2024-10-18	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+34K sh	—	—	34,000
2024-06-12	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−9,806 sh	$45.00	−$441K	57,981
2024-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Legal Officer	AAward	+17.8K sh	—	—	69,782
2024-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Legal Officer	AAward	+957 sh	—	—	70,739
2024-03-01	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−3,756 sh	$53.76	−$202K	67,340
2024-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Legal Officer	AAward	+31.4K sh	—	—	31,400
2024-02-07	EOLSEvolus, Inc.A Award	Director	AAward	+6,464 sh	—	—	37,707
2024-02-07	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,377 sh	—	—	9,377
2024-01-30	EOLSEvolus, Inc.S Sale	Director	SSale	−11.9K sh	$13.14	−$157K	31,243
2023-06-09	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+29.5K sh	—	—	29,532
2023-05-04	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−4,378 sh	$45.00	−$197K	51,982
2023-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Legal Officer	AAward	+2,663 sh	—	—	37,101
2023-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Legal Officer	AAward	+22K sh	—	—	59,101
2023-03-01	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−3,161 sh	$45.25	−$143K	56,139
2023-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Legal Officer	AAward	+39.4K sh	—	—	39,400
2023-01-27	EOLSEvolus, Inc.A Award	Director	AAward	+8,293 sh	—	—	43,174
2023-01-27	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,789
2022-09-08	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-04-21	ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30.4K sh	—	—	30,425
2022-03-07	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−5,140 sh	$62.95	−$324K	34,438
2022-03-01	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−2,886 sh	$66.62	−$192K	25,472
2022-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Legal Officer	AAward	+14K sh	—	—	39,578
2022-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Legal Officer	AAward	+24.9K sh	—	—	24,900
2022-01-24	EOLSEvolus, Inc.A Award	Director	AAward	+15.6K sh	—	—	34,881
2022-01-24	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.7K sh	—	—	22,727
2021-12-22	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.5K sh	—	—	19,495
2021-10-14	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−310 sh	$81.14	−$25.2K	28,358
2021-09-08	RAREUltragenyx Pharmaceutical Inc.M Exercise/Conversion	EVP and Chief Legal Officer	MExercise/Conversion	+7,336 sh	$54.50	+$400K	36,004
2021-09-08	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Legal Officer	SSale	−7,336 sh	$100.65	−$738K	28,668

Recent filings

Accepted (ET)
Aug 44
Parschauer Karah Herdman0001193125-26-332547
SEC(opens sec.gov)
Jun 154
Parschauer Karah Herdman0001677455-26-000002
SEC(opens sec.gov)
May 294
Parschauer Karah Herdman0001193125-26-249114
SEC(opens sec.gov)
Apr 204
Parschauer Karah Herdman0001193125-26-164281
SEC(opens sec.gov)
Mar 104
Parschauer Karah Herdman0001193125-26-100309
SEC(opens sec.gov)
Mar 34
Parschauer Karah Herdman0001193125-26-089111
SEC(opens sec.gov)
Feb 194
Parschauer Karah Herdman0001570562-26-000027
SEC(opens sec.gov)
Sep 124
Parschauer Karah Herdman0001677455-25-000005
SEC(opens sec.gov)
May 304
Parschauer Karah Herdman0000950170-25-079941
SEC(opens sec.gov)
Mar 144
Parschauer Karah Herdman0001570562-25-000046
SEC(opens sec.gov)
Mar 114
Parschauer Karah Herdman0001570562-25-000035
SEC(opens sec.gov)
Mar 44
Parschauer Karah Herdman0000950170-25-032798
SEC(opens sec.gov)
Mar 34
Parschauer Karah Herdman0000950170-25-030639
SEC(opens sec.gov)

Companies

Address

C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT

NOVATO, CA, 94949